St Jude proceeds with Ventritex purchase:
This article was originally published in Clinica
Executive Summary
St Jude Medical is to proceed with its proposed takeover of Ventritex, despite reported failures of a component of Ventritex' Cadence implantable cardioverter defibrillator (see this issue, p 15). St Jude says it still expects to complete the transaction by the end of the first quarter of 1997.